ERCC2 and non-small cell lung carcinoma: For ERCC2 rs13181 (Lys751Gln), grade 2-4 neutropenia was more frequent among individual with 751 Lys/Lys genotype in 62 NSCLC patients treated with cisplatin and docetaxel (p = 0.04) (Isla et al., 2004).